Used as donor PopPK structure for the retatrutide PK bridge the BW^0.8 allometric exponent is internally validated against retatrutide in Rosenstock 2023 arm pairs (4 mg ID2 at 108.3 kg vs 4 mg ID4 at 93.1 kg: predicted Cav,ss ratio 1.13, observed 1.18, 4.8% error), so the borrowing is tirz-prior, reta-confirmed rather than tirz-substituted
Diabetes is a major public health problem that is approaching epidemic proportions globally
The trial is set to conclude in the first quarter of 2027
Prime Therapeutics research Two years, ago, Prime began an analysis to determine the return on investment from a total cost of care perspective when it comes to GLP-1s for weight loss
Post-Weight Loss Skin Tightening at kalon Dermatology At kalon Dermatology, we understand how frustrating it can be to work hard to lose weight only to feel self-conscious about loose skin
In this blog, we will explore more about GLP-1 medications, such as their common GLP-1 agonist side effects, why they occur, and practical ways to manage them effectively